Cholinergic Antagonists: all 1,354 studies that test it
Page 14 of 14. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- Effects of Once Daily Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) of Different SeverityCompletedNCT00274573Phase 3
- A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.CompletedNCT00274560Phase 3
- Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00274547Phase 3
- A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.CompletedNCT00274534Phase 3
- Tiotropium (Spiriva) Rehabilitation StudyCompletedNCT00274521Phase 3
- Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD PatientsCompletedNCT00274508Phase 3
- SPIRIVA in Ususal CareCompletedNCT00274079Phase 4
- Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of SpirivaCompletedNCT00274066Phase 3
- Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPDCompletedNCT00274053Phase 3
- Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPDCompletedNCT00274040Phase 3
- Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva)CompletedNCT00274027Phase 3
- Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory DisordersCompletedNCT00274014Phase 3
- Treatment of Orthostatic IntoleranceActive, not recruitingNCT00262470Phase 1/2
- Analysis of Atropine and Propranolol Induced ChangesCompletedNCT00251602Phase 1
- A Study to Assess the Safety and Efficacy of Different AD 237 Doses in Adults With COPDCompletedNCT00242333Phase 2
- Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00239499Phase 4
- Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPDCompletedNCT00239460Phase 3
- Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPDCompletedNCT00239447Phase 3
- Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).CompletedNCT00239408Phase 4
- The Efficacy and Safety of Gantacurium Chloride for Injection in Tracheal Intubation in Healthy Adult Patients Undergoing Surgery Under General AnesthesiaCompletedNCT00235976Phase 1/2
- Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication.CompletedNCT00230789Phase 4
- Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder SyndromeCompletedNCT00220402Phase 3
- Two Phase Extension Trial of SP668 to Investigate the Safety and Tolerability of Sustained Release Fesoterodine in Subjects With Overactive Bladder: a Double-Blind Phase Followed by an Open-Label Extension PhaseCompletedNCT00220389Phase 2
- Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder SyndromeCompletedNCT00220376Phase 3
- A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder SyndromeCompletedNCT00220363Phase 3
- Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in JapanCompletedNCT00212732Phase 3
- Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in JapanCompletedNCT00212706Phase 2
- Effects of Bronchodilators in Mild Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00202176Phase 4
- A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive BladderCompletedNCT00189800Phase 3
- The Autonomic Nervous System and ObesityCompletedNCT00179023Phase 1
- Efficacy, Safety, and Tolerability of Darifenacin in Patients Aged > 65 Years With Overactive BladderCompletedNCT00171184Phase 4
- A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder.CompletedNCT00171145Phase 3
- Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and OverCompletedNCT00170768Phase 2
- A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive BladderCompletedNCT00170755Phase 3
- Effect of Tiotropium Inhalation Capsules (Spiriva) on Exercise Tolerance in COPD PatientsCompletedNCT00157235Phase 3
- A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00144326Phase 3
- 12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD)CompletedNCT00144196Phase 4
- Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in WomenCompletedNCT00143481Phase 4
- Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release TabletCompletedNCT00139724Phase 3
- Trial to Investigate the Efficacy, Tolerability and Safety of Fesoterodine Sustained Release in Subjects With Overactive Bladder SyndromeCompletedNCT00138723Phase 3
- A Study to Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive BladderCompletedNCT00137397Phase 4
- High Dose Trial in COPDCompletedNCT00128440Phase 2
- A Trial Comparing the Effect of Oral Dimenhydrinate Versus Placebo in Children With GastroenteritisCompletedNCT00124787Phase 4
- A Study to Compare Different Intubating Doses of Zemuron in Pediatric and Adolescent Subjects Under General AnesthesiaCompletedNCT00124722Phase 3
- Childhood Hypertonia of Central Origin: A Trial of Anticholinergic Treatment EffectsCompletedNCT00122044Phase 2
- Single Dose of 1% Tropicamide and 10% Phenylephrine for Pupillary DilationCompletedNCT00120432Phase 3
- An Evaluation of Treatment of Amblyopia in Children 7 To <18 Years OldCompletedNCT00094692Phase 3
- Trial Comparing Daily Atropine Versus Weekend AtropineCompletedNCT00094614Phase 4
- Huperzine A in Alzheimer's DiseaseCompletedNCT00083590Phase 2
- Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging StudiesTerminatedNCT00055575Phase 2
- Amblyopia (Lazy Eye) Treatment StudyCompletedNCT00001864Phase 3
- Lung Health Study (LHS) I and IIICompletedNCT00000568Phase 3
- Evaluation of Benztropine for Cocaine Craving - 2CompletedNCT00000333Phase 2
- Occlusion Versus Pharmacologic Therapy for Moderate AmblyopiaCompletedNCT00000170Phase 3